miR-17∼92 family clusters control iNKT cell ontogenesis via modulation of TGF-β signaling

Edited by Wayne M. Yokoyama, Washington University School of Medicine, St. Louis, MO, and approved November 15, 2016 (received for review July 21, 2016)
December 5, 2016
113 (51) E8286-E8295

Significance

CD1d-restricted invariant natural killer T (iNKT) cells are innate-like T lymphocytes that play fundamental roles in cancer, autoimmunity, and infections. iNKT cells acquire effector functions already in the thymus, because of a distinct developmentally regulated genetic program that is critically controlled by miRNAs. Our study unveils the unexpected requirement for miRNA-dependent fine-tuning of TGF-β signaling in the control of iNKT cell development and functional differentiation. The targeting of a lineage-specific cytokine signaling by miRNA represents a previously unknown level of developmental regulation in the thymus. Furthermore, our study provides a comprehensive atlas of miRNA-regulated molecular pathways involved in iNKT cell ontogenesis, and highlights molecular pathways targeted by defined miRNAs that are predicted to be involved in the development and maturation of CD1d-restricted iNKT cells.

Abstract

Invariant natural killer T cells (iNKT) cells are T lymphocytes displaying innate effector functions, acquired through a distinct thymic developmental program regulated by microRNAs (miRNAs). Deleting miRNAs by Dicer ablation (Dicer KO) in thymocytes selectively impairs iNKT cell survival and functional differentiation. To unravel this miRNA-dependent program, we systemically identified transcripts that were differentially expressed between WT and Dicer KO iNKT cells at different differentiation stages and predicted to be targeted by the iNKT cell-specific miRNAs. TGF-β receptor II (TGF-βRII), critically implicated in iNKT cell differentiation, was found up-regulated in iNKT Dicer KO cells together with enhanced TGF-β signaling. miRNA members of the miR-17∼92 family clusters were predicted to target Tgfbr2 mRNA upon iNKT cell development. iNKT cells lacking all three miR-17∼92 family clusters (miR-17∼92, miR-106a∼363, miR-106b∼25) phenocopied both increased TGF-βRII expression and signaling, and defective effector differentiation, displayed by iNKT Dicer KO cells. Consistently, genetic ablation of TGF-β signaling in the absence of miRNAs rescued iNKT cell differentiation. These results elucidate the global impact of miRNAs on the iNKT cell developmental program and uncover the targeting of a lineage-specific cytokine signaling by miRNAs as a mechanism regulating innate-like T-cell development and effector differentiation.

Continue Reading

Data Availability

Data deposition: The data reported in this paper have been deposited in the Gene Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession no. GSE79901).

Acknowledgments

We thank Giovanni Tonon for the critical reading of the manuscript, and the NIH Tetramer Core Facility for mouse CD1d tetramer. The study was funded by Fondazione Cariplo Grant 2009–3603 (to S.A. and P.D.) and Italian Association for Cancer Research Grant AIRC IG15466 and IG15517 (to P.D. and G.C.).

Supporting Information

Supporting Information (PDF)
Supporting Information
pnas.1612024114.sd01.xlsx

References

1
A Bendelac, PB Savage, L Teyton, The biology of NKT cells. Annu Rev Immunol 25, 297–336 (2007).
2
PJ Brennan, M Brigl, MB Brenner, Invariant natural killer T cells: An innate activation scheme linked to diverse effector functions. Nat Rev Immunol 13, 101–117 (2013).
3
A Bendelac, Selection and adaptation of cells expressing major histocompatibility complex class I-specific receptors of the natural killer complex. J Exp Med 186, 349–351 (1997).
4
DG Pellicci, et al., A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage. J Exp Med 195, 835–844 (2002).
5
K Benlagha, T Kyin, A Beavis, L Teyton, A Bendelac, A thymic precursor to the NK T cell lineage. Science 296, 553–555 (2002).
6
YJ Lee, KL Holzapfel, J Zhu, SC Jameson, KA Hogquist, Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat Immunol 14, 1146–1154 (2013).
7
M Fedeli, et al., Dicer-dependent microRNA pathway controls invariant NKT cell development. J Immunol 183, 2506–2512 (2009).
8
L Zhou, et al., Tie2cre-induced inactivation of the miRNA-processing enzyme Dicer disrupts invariant NKT cell development. Proc Natl Acad Sci USA 106, 10266–10271 (2009).
9
NA Bezman, T Chakraborty, T Bender, LL Lanier, miR-150 regulates the development of NK and iNKT cells. J Exp Med 208, 2717–2731 (2011).
10
Q Zheng, L Zhou, QS Mi, MicroRNA miR-150 is involved in Vα14 invariant NKT cell development and function. J Immunol 188, 2118–2126 (2012).
11
A Burocchi, et al., Regulated expression of miR-155 is required for iNKT cell development. Front Immunol 6, 140 (2015).
12
J Henao-Mejia, et al., The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis. Immunity 38, 984–997 (2013).
13
N Ziętara, et al., Critical role for miR-181a/b-1 in agonist selection of invariant natural killer T cells. Proc Natl Acad Sci USA 110, 7407–7412 (2013).
14
LA Pobezinsky, et al., Let-7 microRNAs target the lineage-specific transcription factor PLZF to regulate terminal NKT cell differentiation and effector function. Nat Immunol 16, 517–524 (2015).
15
BS Cobb, et al., A role for Dicer in immune regulation. J Exp Med 203, 2519–2527 (2006).
16
H Guo, NT Ingolia, JS Weissman, DP Bartel, Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835–840 (2010).
17
DG Hendrickson, et al., Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA. PLoS Biol 7, e1000238 (2009).
18
, eds G Parmigiani, ES Garett, RA Irizarry, SL Zeger (Springer, New York The Analysis of Gene Expression Data: Methods and Software, 2003).
19
SA Muljo, et al., Aberrant T cell differentiation in the absence of Dicer. J Exp Med 202, 261–269 (2005).
20
JL Matsuda, et al., T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells. Blood 107, 2797–2805 (2006).
21
NR Cohen, et al., Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells. Nat Immunol; ImmGen Project Consortium 14, 90–99 (2013).
22
JM Doisne, et al., iNKT cell development is orchestrated by different branches of TGF-beta signaling. J Exp Med 206, 1365–1378 (2009).
23
C Havenar-Daughton, S Li, K Benlagha, JC Marie, Development and function of murine RORγt+ iNKT cells are under TGF-β signaling control. Blood 119, 3486–3494 (2012).
24
CP Concepcion, C Bonetti, A Ventura, The microRNA-17-92 family of microRNA clusters in development and disease. Cancer J 18, 262–267 (2012).
25
S Jiang, et al., Molecular dissection of the miR-17-92 cluster’s critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation. Blood 118, 5487–5497 (2011).
26
CJ Jung, et al., Human ESC self-renewal promoting microRNAs induce epithelial-mesenchymal transition in hepatocytes by controlling the PTEN and TGFβ tumor suppressor signaling pathways. Mol Cancer Res 10, 979–991 (2012).
27
Z Li, CS Yang, K Nakashima, TM Rana, Small RNA-mediated regulation of iPS cell generation. EMBO J 30, 823–834 (2011).
28
AM Lakner, et al., Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis. Hepatology 56, 300–310 (2012).
29
A Ventura, et al., Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132, 875–886 (2008).
30
SG Kang, et al., MicroRNAs of the miR-17∼92 family are critical regulators of T(FH) differentiation. Nat Immunol 14, 849–857 (2013).
31
D Baek, et al., The impact of microRNAs on protein output. Nature 455, 64–71 (2008).
32
CR Chen, Y Kang, PM Siegel, J Massagué, E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression. Cell 110, 19–32 (2002).
33
L Gorelik, S Constant, RA Flavell, Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J Exp Med 195, 1499–1505 (2002).
34
L Gorelik, PE Fields, RA Flavell, Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol 165, 4773–4777 (2000).
35
XH Feng, X Lin, R Derynck, Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta. EMBO J 19, 5178–5193 (2000).
36
GM Wildey, S Patil, PH Howe, Smad3 potentiates transforming growth factor beta (TGFbeta )-induced apoptosis and expression of the BH3-only protein Bim in WEHI 231 B lymphocytes. J Biol Chem 278, 18069–18077 (2003).
37
S Waldegger, et al., h-sgk serine-threonine protein kinase gene as transcriptional target of transforming growth factor beta in human intestine. Gastroenterology 116, 1081–1088 (1999).
38
J Avouac, et al., Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis. Arthritis Rheum 64, 1642–1652 (2012).
39
LA Wolfraim, TM Walz, Z James, T Fernandez, JJ Letterio, p21Cip1 and p27Kip1 act in synergy to alter the sensitivity of naive T cells to TGF-beta-mediated G1 arrest through modulation of IL-2 responsiveness. J Immunol 173, 3093–3102 (2004).
40
L Tian, et al., Loss of T cell microRNA provides systemic protection against autoimmune pathology in mice. J Autoimmun 38, 39–48 (2012).
41
M Dews, et al., The myc-miR-17∼92 axis blunts TGFbeta signaling and production of multiple TGFbeta-dependent antiangiogenic factors. Cancer Res 70, 8233–8246 (2010).
42
P Mestdagh, et al., The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma. Mol Cell 40, 762–773 (2010).
43
F Petrocca, A Vecchione, CM Croce, Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res 68, 8191–8194 (2008).
44
KA Lê Cao, et al., mixOmics: Omics Data Integration Project. R package Version 6.1.1. Available at https://CRAN.R-project.org/package=mixOmics. Accessed November 24, 2016. (2016).
45
; R-Core-Team R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, Austria, 2012).
46
GK Smyth Limma: Linear Models for Microarray Data (Springer, New York, 2005).
47
W Huang, BT Sherman, RA Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44–57 (2009).
48
W Huang, BT Sherman, RA Lempicki, Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37, 1–13 (2009).
49
G Yu, et al., GOSemSim: An R package for measuring semantic similarity among GO terms and gene products. Bioinformatics 26, 976–978 (2010).
50
R Edgar, M Domrachev, AE Lash, Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30, 207–210 (2002).
51
BP Lewis, CB Burge, DP Bartel, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15–20 (2005).

Information & Authors

Information

Published in

The cover image for PNAS Vol.113; No.51
Proceedings of the National Academy of Sciences
Vol. 113 | No. 51
December 20, 2016
PubMed: 27930306

Classifications

Data Availability

Data deposition: The data reported in this paper have been deposited in the Gene Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession no. GSE79901).

Submission history

Published online: December 5, 2016
Published in issue: December 20, 2016

Keywords

  1. NKT cells
  2. miRNA
  3. TGF-β
  4. development
  5. CD1d

Acknowledgments

We thank Giovanni Tonon for the critical reading of the manuscript, and the NIH Tetramer Core Facility for mouse CD1d tetramer. The study was funded by Fondazione Cariplo Grant 2009–3603 (to S.A. and P.D.) and Italian Association for Cancer Research Grant AIRC IG15466 and IG15517 (to P.D. and G.C.).

Notes

This article is a PNAS Direct Submission.

Authors

Affiliations

Maya Fedeli
Experimental Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, 20132 Milan, Italy;
Michela Riba
Genome Function Unit, Center for Translational Genomics and Bioinformatics, San Raffaele Scientific Institute, 20132 Milan, Italy;
Jose Manuel Garcia Manteiga
Genome Function Unit, Center for Translational Genomics and Bioinformatics, San Raffaele Scientific Institute, 20132 Milan, Italy;
Lei Tian
Autoimmune Genetics Laboratory, Vlaams Instituut voor Biotechnologie, Katholieke Universiteit, 3000 Leuven, Belgium;
Valentina Viganò
Experimental Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, 20132 Milan, Italy;
Grazisa Rossetti
National Institute of Molecular Genetics, 20122 Milan, Italy;
Massimiliano Pagani
National Institute of Molecular Genetics, 20122 Milan, Italy;
Changchun Xiao
Department of Immunology and Microbial Science; The Scripps Research Institute, La Jolla, CA 92037;
Adrian Liston
Autoimmune Genetics Laboratory, Vlaams Instituut voor Biotechnologie, Katholieke Universiteit, 3000 Leuven, Belgium;
Elia Stupka
Genome Function Unit, Center for Translational Genomics and Bioinformatics, San Raffaele Scientific Institute, 20132 Milan, Italy;
Genome Function Unit, Center for Translational Genomics and Bioinformatics, San Raffaele Scientific Institute, 20132 Milan, Italy;
Sergio Abrignani
National Institute of Molecular Genetics, 20122 Milan, Italy;
Paolo Provero
Genome Function Unit, Center for Translational Genomics and Bioinformatics, San Raffaele Scientific Institute, 20132 Milan, Italy;
Department of Molecular Biotechnology and Health Sciences, University of Turin, 10124 Turin, Italy
Paolo Dellabona1 [email protected]
Experimental Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, 20132 Milan, Italy;
Giulia Casorati1 [email protected]
Experimental Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, 20132 Milan, Italy;

Notes

1
To whom correspondence may be addressed. Email: [email protected] or [email protected].
Author contributions: M.F., P.D., and G.C. designed research; M.F., L.T., and V.V. performed research; G.R., M.P., C.X., A.L., and S.A. contributed new reagents/analytic tools; M.F., M.R., J.M.G.M., E.S., D.C., and P.P. analyzed data; and M.F., P.D., and G.C. wrote the paper.

Competing Interests

The authors declare no conflict of interest.

Metrics & Citations

Metrics

Note: The article usage is presented with a three- to four-day delay and will update daily once available. Due to ths delay, usage data will not appear immediately following publication. Citation information is sourced from Crossref Cited-by service.


Altmetrics

Citations

Export the article citation data by selecting a format from the list below and clicking Export.

Cited by

    Loading...

    View Options

    View options

    PDF format

    Download this article as a PDF file

    DOWNLOAD PDF

    Login options

    Check if you have access through your login credentials or your institution to get full access on this article.

    Personal login Institutional Login

    Recommend to a librarian

    Recommend PNAS to a Librarian

    Purchase options

    Purchase this article to access the full text.

    Single Article Purchase

    miR-17∼92 family clusters control iNKT cell ontogenesis via modulation of TGF-β signaling
    Proceedings of the National Academy of Sciences
    • Vol. 113
    • No. 51
    • pp. 14463-E8358

    Figures

    Tables

    Media

    Share

    Share

    Share article link

    Share on social media